$TPAC Indeed, plenty of shares moving around, mostly from

New Post Public Reply Private Reply Replies (2) Message Board
Mysterium CajunPhil #13257
$TPAC Indeed, plenty of shares moving around, mostly from existing preferred shares to commons. Some of the movement appears to be assisting those assisting us, such as the consulting team, and some, which I am still in the dark on, which have a purpose of which I will, for the moment, title as undisclosed.

The undisclosed, I'm sure readers would like more clarity on, though, if they are serving a purpose with companies we are in business with and are not yet at liberty to disclose, as to not repeat the Timken issue, it may be better left as is, at least for the time being. IR may be able to answer the question in regards to those in a capacity that I am not privy to.

That said, there was also an upside to the set of excerpts you brought to attention. Such as the following:

"2. During the nine months ended July 31, 2016, we issued 29,000,000 shares of common stock to consultants in consideration of services rendered. The shares were valued at $81,600 based on the closing stock prices on the dates of the stock grants.. The issuances were exempt pursuant to Section 4(a)(2) of the Securities Act."
In our April 2016 10-Q we erroneously reported that we issued 358,000,000 shares of our common stock to consultants for services rendered during the six months ended April 30, 2016. As described above, 279,000,000 of these shares of our common stock were actually issued upon conversion of 279 shares of our preferred stock during the six months ended April 30, 2016 and were improperly allocated as shares issued to consultants for services rendered in the April 2016 10-Q. Further, 50,000,000 shares of our common stock previously described in our April 2016 10-Q as shares issued to consultants for services rendered were erroneously issued and have subsequently been cancelled


My favorite part being:

"In our April 2016 10-Q we erroneously reported that we issued 358,000,000 shares of our common stock to consultants for services rendered during the six months ended April 30, 2016. As described above, 279,000,000 of these shares of our common stock were actually issued upon conversion of 279 shares of our preferred stock during the six months ended April 30, 2016 and were improperly allocated as shares issued to consultants for services rendered in the April 2016 10-Q. Further, 50,000,000 shares of our common stock previously described in our April 2016 10-Q as shares issued to consultants for services rendered were erroneously issued and have subsequently been cancelled"

While no one wants to see an error in regards to SS, let's remember what we saw in Feb. There was a big panic over the SS issue, even in spite of the 8-k's showing retirement installments, in the end, only to be the case that Bill was honest and there was a mere clerical error.

That said, in this case, I am reading it as more favorable, at least in the context of the admission of an error. More shares were said to be converted than actually was the case. That to me, is a good sign, especially in stark contrast to the consideration of the reverse.

The tale of the tape will be in comparing the most recently disclosed SS numbers, whether on the filing or Muse feed, with the most up to date SS numbers available. I will make that request to IR after writing this to have them contact the T/A and post on Twitter most recent numbers after hearing back from the T/A. I see nothing to get excited about until then, good or bad.

As per your other request for assistance, I would contact IR about that or even NVSOS. If the WG LTD is out there, which I would guess to be the case, one of those two entities should be able to assist in clarification and should be able to link you to proof of existence.

I hope that assists in the process of deciphering. Some may see it differently and it would be great to see any other points of view on the matter.
1

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Innovative Thought Leadership: TLFT 2025 Awards

Updated Category News Views 401

Celebrating Innovative Thought Leadership Accenture, KPMG, and Elsevier have been honored for their groundbreaking accomplishments in thought leadership, showcasing their significant influence across brand development, social impact, and industry standards. Recognition at the TLFT 2025 Awards iResearch Services has proudly unveiled the winners of the prestigious TLFT 2025...

Continue Reading
Aquestive Therapeutics Boosts Stock Target After Event Insights

Updated Category News Views 57

Aquestive Therapeutics made headlines back in 2024 with its stock getting a price target bump to $10 from H.C. Wainwright. This was right after they rolled out updates at a virtual investor event where they pitched their cutting-edge Adrenaverse technology. Traders were buzzing—was this the kind of news that’d drive shares up? Turns out, it was more than just fluff;...

Continue Reading
Valneva Collaborates with LimmaTech on Shigella Vaccine Study

Updated Category News Views 63

Valneva Begins Clinical Trials for Innovative Shigella Vaccine Valneva SE, a prominent specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech firm, have recently marked a significant milestone in vaccine research. They announced the initial vaccination in a pivotal Phase 2b controlled human infection model (CHIM) study focused on their tetravalent...

Continue Reading
Innovative Vehicle Accessory Enhances Road Safety Efforts

Updated Category News Views 194

Introducing a Revolutionary Vehicle Safety Accessory Every day, drivers encounter various challenges on the road, from navigating busy intersections to spotting pedestrians or hidden traffic signs. An innovative inventor recognized these challenges and developed the CORNER CAMERA, an inventive solution aimed at improving road safety for everyone. Understanding the CORNER...

Continue Reading
California Northstate University Celebrates Key Accreditation Milestone

Updated Category News Views 159

California Northstate University Announces Full Accreditation California Northstate University (CNU) has achieved a significant milestone by securing full accreditation for its College of Medicine from the Liaison Committee on Medical Education (LCME). This achievement underscores CNU’s unwavering dedication to promoting educational excellence, innovation, and the...

Continue Reading